The role of CX3CL1 and ADAM17 in pathogenesis of diffuse parenchymal lung diseases
E. Tedlova (Bratislava, Slovakia), J. Urban (Vysne Hagy, Slovakia), M. Suchankova (Bratislava, Slovakia), M. Ganovska (Vysne Hagy, Slovakia), V. Leksa (Bratislava, Slovakia), F. Sandor (Bratislava, Slovakia), B. Konig (Bratislava, Slovakia), I. Jonner (Vysne Hagy, Slovakia), M. Bucova (Bratislava, Slovakia)
Source: Virtual Congress 2021 – Translational and other aspects of idiopathic interstitial pneumonia
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. Tedlova (Bratislava, Slovakia), J. Urban (Vysne Hagy, Slovakia), M. Suchankova (Bratislava, Slovakia), M. Ganovska (Vysne Hagy, Slovakia), V. Leksa (Bratislava, Slovakia), F. Sandor (Bratislava, Slovakia), B. Konig (Bratislava, Slovakia), I. Jonner (Vysne Hagy, Slovakia), M. Bucova (Bratislava, Slovakia). The role of CX3CL1 and ADAM17 in pathogenesis of diffuse parenchymal lung diseases. 3277
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: